- Home
- VNO vs ACHC Comparison
VNO vs ACHC Comparison
Compare VNO & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VNO | ACHC |
|---|---|---|
| Founded | 1946 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VNO | ACHC |
|---|---|---|
| Price | $33.28 | $14.42 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $37.67 | $24.00 |
| AVG Volume (30 Days) | 1.5M | ★ 3.6M |
| Earning Date | 02-09-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.20 | 1.18 |
| Revenue | $1,903,939,000.00 | ★ $3,265,548,000.00 |
| Revenue This Year | N/A | $6.50 |
| Revenue Next Year | $2.19 | $4.38 |
| P/E Ratio | ★ $7.95 | $12.22 |
| Revenue Growth | 1.75 | ★ 4.58 |
| 52 Week Low | $29.68 | $12.63 |
| 52 Week High | $45.37 | $47.08 |
Technical Indicators
Market Signals| Indicator | VNO | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 36.29 | 36.71 |
| Support Level | $34.27 | $13.95 |
| Resistance Level | $35.68 | $14.94 |
| Average True Range (ATR) | 0.97 | 0.85 |
| MACD | -0.09 | 0.21 |
| Stochastic Oscillator | 6.96 | 42.35 |
Price Performance
Historical ComparisonAbout VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.